Lineage Cell Therapeutics, Inc. financial data

Symbol
LCTX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
2173 Salk Avenue, Suite 200, Carlsbad, California
State of incorporation
California
Fiscal year end
December 31
Former names
BIOTIME INC (to 8/8/2019)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 255 % -15.8%
Debt-to-equity 55.8 % -13.2%
Return On Equity -36.3 % -19.4%
Return On Assets -23.1 % -25.9%
Operating Margin -414 % -84.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 189M shares +7.92%
Common Stock, Shares, Outstanding 189M shares +8.25%
Entity Public Float 186M USD -7.48%
Common Stock, Value, Issued 468M USD +4.39%
Weighted Average Number of Shares Outstanding, Basic 189M shares +10.7%
Weighted Average Number of Shares Outstanding, Diluted 189M shares +10.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 6.19M USD -41.2%
Revenue from Contract with Customer, Excluding Assessed Tax 6.19M USD -56.3%
Cost of Revenue 567K USD -2.74%
Research and Development Expense 13.5M USD -14.2%
General and Administrative Expense 17.7M USD -0.3%
Costs and Expenses 7.28M USD -11.8%
Operating Income (Loss) -25.6M USD -8.66%
Nonoperating Income (Expense) 1.39M USD +566%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -24.2M USD -3.67%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -24.2M USD -9.82%
Earnings Per Share, Basic -0.14 USD/shares -7.69%
Earnings Per Share, Diluted -0.14 USD/shares -7.69%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 29.6M USD -12.6%
Marketable Securities, Current 8.87M USD -26.3%
Accounts Receivable, after Allowance for Credit Loss, Current 235K USD -47%
Assets, Current 40.4M USD -16.7%
Property, Plant and Equipment, Net 2.02M USD -62%
Operating Lease, Right-of-Use Asset 2.58M USD
Intangible Assets, Net (Excluding Goodwill) 46.5M USD -0.19%
Goodwill 10.7M USD 0%
Assets 103M USD -7.96%
Accounts Payable, Current 2.39M USD +9.19%
Employee-related Liabilities, Current 2.22M USD +15.6%
Accrued Liabilities, Current 414K USD -28.7%
Contract with Customer, Liability, Current 10.1M USD -72.4%
Liabilities, Current 15.3M USD -4.84%
Contract with Customer, Liability, Noncurrent 21.2M USD
Deferred Income Tax Liabilities, Net 273K USD 0%
Operating Lease, Liability, Noncurrent 1.77M USD -23.3%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 35.9M USD -11.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.47M USD +5.4%
Retained Earnings (Accumulated Deficit) -397M USD -6.49%
Stockholders' Equity Attributable to Parent 68.3M USD -6.01%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 66.9M USD -6.15%
Liabilities and Equity 103M USD -7.96%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.78M USD +48.6%
Net Cash Provided by (Used in) Financing Activities 14M USD
Net Cash Provided by (Used in) Investing Activities -38K USD -100%
Common Stock, Shares Authorized 450M shares +80%
Common Stock, Shares, Issued 189M shares +8.25%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.13M USD +99%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 30.2M USD -12.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2K USD 0%
Deferred Tax Assets, Valuation Allowance 80.5M USD +2.95%
Deferred Tax Assets, Gross 85.2M USD +8.3%
Operating Lease, Liability 2.84M USD
Payments to Acquire Property, Plant, and Equipment 38K USD -79.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -24M USD -13%
Lessee, Operating Lease, Liability, to be Paid 2.38M USD
Operating Lease, Liability, Current 1.07M USD +14.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 508K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 531K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 330K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 486K USD
Deferred Tax Assets, Operating Loss Carryforwards 63.5M USD +7.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 2.96M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 407K USD
Operating Lease, Payments 302K USD -4.13%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 0 USD -100%
Depreciation, Depletion and Amortization 138K USD -8%
Deferred Tax Assets, Net of Valuation Allowance 4.73M USD +847%
Share-based Payment Arrangement, Expense 1.27M USD -0.86%